"Baylor Scott & White Medical Center – Plano is a full-service hospital serving patients in and around Plano. Open 24 hours a day, every day, the specialists at the medical center provide care to patients in the areas of allergy and immunology, ENT, back pain, imaging, cancer care, heart condition, dermatology, surgery, urology, wound care, and more."

During the past decade, Baylor Scott White - Plano conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Scott White - Plano" #1 sponsor was "Actelion" with 4 trials, followed by "Baylor Research Institute" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "On-X Life Technologies, Inc." with 2 trials sponsored and "3M" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Scott White - Plano" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Acelis Connected Health" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "NAMSA" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Scott White - Plano" are "Pulmonary Arterial Hypertension" (4 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Aortic Aneurysm" (1 trials), "Aortic Dissection" (1 trials) and "Aortic Stenosis" (1 trials). Many other conditions were trialed in "Baylor Scott White - Plano" in a lesser frequency.

Most popular intervention types in "Baylor Scott White - Plano" are "Device" (12 trials), "Drug" (9 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Macitentan 10 mg" (2 trials), "ACURATE Prime™ Transfemoral TAVR System XL" (1 trials) and "ACURATE neo2™ Transfemoral TAVR System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Scott White - Plano" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Scott White - Plano". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Baylor Scott White - Plano, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Scott White - Plano, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".